soluble ErbB3 theragnostics (TBIG)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesoluble ErbB3 theragnostics (TBIG)
Drug Alias NamesErbB3 theragnostics (TBIG)p85-sErbB3 (TBIG)sHer theragnostics (TBIG)soluble Her theragnostics (TBIG)p85-sErbB3
ClassificationBiologics > Protein drugs > Recombinant polypeptideDiagnostic agent (In vivo)
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 antagonistsNeuregulin-1 inhibitorsReceptor protein-tyrosine kinase erbB-4 antagonists +[4] 
TargetsNeuregulin-1Receptor protein-tyrosine kinase erbB-2Receptor tyrosine-protein kinase erbB-3 +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTumor Biology Investment Group Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTumor Biology Investment Group Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A